SEMINARA, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 2.998
EU - Europa 1.159
AS - Asia 497
SA - Sud America 19
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.687
Nazione #
US - Stati Uniti d'America 2.971
UA - Ucraina 308
SE - Svezia 239
IT - Italia 189
SG - Singapore 184
IN - India 159
DE - Germania 132
CN - Cina 128
FI - Finlandia 106
RU - Federazione Russa 44
GB - Regno Unito 35
BG - Bulgaria 31
FR - Francia 26
CA - Canada 22
AR - Argentina 19
IE - Irlanda 19
TR - Turchia 14
BE - Belgio 10
RO - Romania 8
TG - Togo 7
MX - Messico 5
ZA - Sudafrica 5
CH - Svizzera 4
ID - Indonesia 3
JP - Giappone 3
KR - Corea 3
NL - Olanda 3
HR - Croazia 2
IR - Iran 2
LU - Lussemburgo 2
AU - Australia 1
EU - Europa 1
LV - Lettonia 1
PH - Filippine 1
Totale 4.687
Città #
Fairfield 403
Woodbridge 300
Chandler 230
Houston 192
Ann Arbor 185
Ashburn 163
Seattle 144
Jacksonville 133
Wilmington 124
Princeton 119
Singapore 119
Cambridge 118
Rome 93
Plano 92
Beijing 91
Boston 48
Santa Clara 42
San Diego 34
Millbury 33
Sofia 31
Lawrence 28
Boardman 27
Dearborn 26
Andover 24
San Paolo di Civitate 23
Dublin 19
Federal 19
Helsinki 18
Norwalk 16
Istanbul 14
Moscow 12
Bremen 10
Brussels 9
Ottawa 9
Falkenstein 8
Fasano 8
Toronto 8
Falls Church 7
Lomé 7
Los Angeles 7
Mannheim 7
Bühl 6
Fremont 6
Auburn Hills 5
Hefei 5
Jinan 5
London 5
Fort Worth 4
Muizenberg 4
Nanchang 4
Nanjing 4
New York 4
Orta di Atella 4
Prineville 4
Caserta 3
Elora 3
Grafing 3
Indiana 3
Jakarta 3
Phoenix 3
Pittsburgh 3
Washington 3
Baotou 2
Bari 2
Bern 2
Bracciano 2
Buffalo 2
Ciampino 2
Flushing 2
Kunming 2
Latina 2
Laurel 2
Luxembourg 2
Mexico City 2
Milan 2
Newark 2
Philadelphia 2
Redmond 2
Redwood City 2
Rocca Priora 2
Southwark 2
Yellow Springs 2
Zhengzhou 2
Afragola 1
Airola 1
Alatri 1
Arezzo 1
Ariccia 1
Arnsberg 1
Burton-on-Trent 1
Carini 1
Chongqing 1
Crotone 1
Dallas 1
Frosinone 1
Fuzhou 1
Hebei 1
Henderson 1
Hialeah 1
Holts Summit 1
Totale 3.143
Nome #
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: a real-world experience 122
CANCER-ASSOCIATED HEMOLYTIC-UREMIC SYNDROME WITH SPONTANEOUS RESOLUTION - A CASE-REPORT 97
Circulating tumor cells in right-and left-sided colorectal cancer 95
Chronic neutrophilic leukemia and myeloma. Report on long survival. 94
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study. 94
Evaluation of the relation between radionucleotide fractional incorporation and in vitro chemosensitivity of colorectal tumors 94
INTERDIGITATING RETICULUM CELL AND LYMPHOPROLIFERATIVE DISEASE:POSSIBLE CORRELATIONS BETWEEN SKIN AND THYMUS-DEPENDENT LYMPHOCYTE SYSTEM REVISITED 90
Vascular endothelial growth factor inhibitor therapy and cardiovascular and renal damage in renal cell carcinoma 88
Cancer Chemotherapy and Cardiovascular Risks: Is Capecitabine-Induced Hypertriglyceridemia a Rare Adverse Effect? 86
Metronomic Chemotherapy with Vinblastine in the paliation of advanced cancers: Variation of serum VEGF levels is a biomarker predictive of tumor response to antiangiogenetic therapy. 84
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey. 81
T and B lymphocytes: two different cell populations for the "first defence barrier" at cutaneous and mucosal levels? 74
Epirubicin, Cisplatin and continuous infusion 5-Fluorouracil (ECF regimen) in the treatment of advanced colorectal cancer 73
An unusual presentation of multiple cavitated lung metastases from colon carcinoma. 71
Fasting plasma amino acid imbalance in untreated cancer patients. 71
Discoloration of the nails and early anemia after mitoxantrone, folinic acid and 5-Fluorouracil. 71
Activity of ruboxyl, a nitroxyl derivative of daunorubicin, on experimental models of colorectal cancer metastases 70
In vitro models of a three-drug regimen (epirubicin, cisplatin and fluorouracil) for the treatment of colorectal cancer 70
OR018: Cancer Anorexia: Assessment of Hypothalamic Dysfunction by Functional Magnetic Resonance Imaging (FMRI) and Its Association with Inflammation, Ghrelin, and Leptin in Lung Cancer Patients 69
Searching for evidence to support the use of ginger in the prevention of chemotherapy-induced nausea and vomiting 69
5-Fluorouracil (FU) with folinic acid (FA) and Mitomycin c (MMC)in the adjuvant treatment of colorectal carcinoma. Part II. Evaluation of toxicity. 69
DRUG SENSITIVITY OF DIFFERENT TUMOR LESIONS FROM THE SAME PATIENT EVALUATED BY A SHORT-TERM ASSAY 68
ELEVATED DOSES OF CARMUSTINE AND MITOMYCIN-C, WITH LONIDAMINE ENHANCEMENT AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER - RESULTS FROM A PILOT-STUDY 67
Antiangiogenic metronomic Chemotherapy and hyperthermia in palliation of advanced cancer. 67
Kinetic characterisation in needle biopsies of hepatocellular carcinama: feasibility and preliminari results. 66
A new anthracycline regimen for prolymphocytic leukemia? Study of a case report with flow cytometric implications. 66
High-dose chemotherapy with bone marrow transplantation for advanced colorectal carcer: report on toxicity 65
Long-lasting response to vinorelbine in unresectable non-small cell lung carcinoma: A case with concomitant good quality of life 63
Is CEA better than CYFRA 21-1 in the monitoring of squamous cell lung cancer progression? 62
COMPARATIVE IN VITRO AND IN VIVO STUDY OF A NITROXYL DERIVATIVE OF 5-FLUOROURACIL (MAGNIZIL) ON HUMAN GASTROINTESTINAL TUMORS 62
Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an italian survey. 61
Darbepoetin in the control of cancer-related anaemia 61
Mytomicin C and Etoposide in advanced colorectal carcinoma: a clinical and in vitro experience that focuses the problem of schedule-dependence in combination therapy 61
Capecitabine-Vinorelbine combined chemotherapy in real-lyfe clinical practice: safe and effective treatment in elderly patients with metastatic breast cancer. 60
Clinical course and phenotypic instability in 4 cases of multiple myeloma: a biological model of tumors 60
Tossicità della'associazione acido folinico, fluorouracile, mitomicina C come terapia adiuvante nel cancro del colon-retto 59
ALTERNATING INTRAVENOUS COURSES OF MELPHALAN AND PEPTICHEMIO IN HIGH-RISK MULTIPLE-MYELOMA - (PRELIMINARY-RESULTS) 59
Favorable toxicity profile of raltitrexed in elderly patients treated for colorectal cancer: A case series 58
IS THERAPY WITH CYTOSTATICS OBSOLETE IN HAIRY-CELL LEUKEMIA 58
Evaluation of in vitro Adriamycin and Adriamycin-analogues activity in colo-rectal carcinoma and its metastases. 54
High-dose chemotherapy with autologous bone marrow transplantation, in the treatment of Advanced colorectal cancer. 54
EVALUATION OF BONE MINERAL DENSITY (BMD) IN EARLY BREAST CANCER (EBC) PATIENTS TREATED WITH UP-FRONT OR SWITCH SCHEDULES OF AROMATASE INHIBITORS (AIS): RESULTS OF A SINGLE CENTRE RETROSPECTIVE STUDY 54
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? 54
Cytosine arabinoside-induced differentiation and killing: Unresolved questions 51
DOSE-INTENSE 5-FLUOROURACIL IN COLORECTAL-CANCER 51
AN INVITRO ASSAY TO ANALYZE CROSS RESISTANCE IN HUMAN-TUMORS. 49
High-dose chemotherapy + ABMT in advaced colorectal carcinoma: different response of hepatic and extra-hepatic metastases. 47
Effect of Ruboxil (nitroxyl derivative of daunomicin) on hepatic metastases of colorectal carcinoma 47
Studio in vitro sulla chemiosensibilità dei tumori primitivi e metastatici del retto-colon. 46
Intra-articular methotrexate in the therapy of rheumatoid arthritis 46
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high dose cisplatin 44
Activity of a nitroxylated analog of Daunomicin, Ruboxyl, in B-lymphoproliferative disorders 44
Nucleotide fractional incorporation: a simple metabolic feature potentially related to clinical outcome in colorectal cancer patients 43
Cell kinetics of primary and metastatic lesions in patients with gastrointestinal tumors. 43
Anorexia in cancer patients: evaluation of hypothalamic dysfunction by functional magnetic resonance imaging (fMRI) and its association with inflammation, ghrelin and leptin 43
Non secretory and Hyposecretory Multiple Myeloma: a ten years experience. 42
La glutamina aumenta la chemiosensibilità delle linee cellulari tumorali in vitro 42
Relation between cell cycle perturbations and potentiating effect of modulators on conventional antitumor drugs. 40
ANTHRACYCLINE IN COLORECTAL-CARCINOMA - AN INVITRO SHORT-TERM ASSAY TO PREDICT DRUG SENSITIVITY - PRELIMINARY-RESULTS 39
Long-term disease free survival (DFS) in patients with small breast cancer: clinical relevance of traditional and new prognostic factors in a retrospective study 39
In vitro effect of a nitroxyl-derivative of Daunorubicin (Ruboxyl) on colo-rectal cancer. 38
CELL-KINETICS OF GASTROINTESTINAL TUMORS AFTER DIFFERENT NUTRITIONAL REGIMENS - A PRELIMINARY-REPORT 38
Preclinical and clinical studies of chemotherapeutic strategies in colorectal cancer patients 36
RESTORATION OF IMMUNE FUNCTIONS AFTER CHEMOTHERAPY 36
Evaluation of hypothalamic activity in cancer anorexia by functional magnetic resonance 35
HYPEREOSINOPHILIC SYNDROME AND PLASMOCYTOMA, REPORT OF A CASE AND REVIEW OF THE LITERATURE 34
Cell kinetics perturbation due to nutritional manipolation in gastrointestinal tumors. 34
Unusual course of a case of Hodgkin's disease treated with chemoimmunotherapy (BCG + Sternberg cell vaccine): a retrospective analysis. 34
Effect of cisplatin administration on plasma tryptophan levels: an in vivo study. 34
Her2-positive early brest cancer in the pre-Trastuzumab and Trastuzumab eras: a triple positive subgroup analysis of a multicenter retrospective study 34
Ectodermal immunity and its significance in oncogenesis: material for a hypothesis. 32
La relazione medico-paziente in oncologia 32
Embryo extracts opotherapy reduces A-fetoprotein levels in hepatocellular carcinoma patients 31
Interferon as a sensitizing agent toward chemotherapy in case of multiple myeloma refractory to treatment 31
The surgeon's decision as a prognostic factor in a pool of patients with colorectal cancer coming from different institutions 30
Effect of energy substrate manipulation on tumor-cell proliferation in parenterally fed cancer-patients 30
Lung pseudometastases due to Vimblastine therapy 30
THE NON-PRODUCER PLASMA-CELL MYELOMA - REPORT OF A CASE AND REVIEW OF THE LITERATURE 28
The relationship between arthralgia and accelerated bone loss in early breast cancer (EBC) patients with up-front or swith schedules of aromatase inhibitors (AIs): retrospective analysis of incidence and responcse to supplementary comedications. 28
Cancer anorexia: hypothalamic dysfunction and its association with inflammation and appetite-regulating peptides in lung cancer patients 28
FRACTIONAL INCORPORATION OF RADIONUCLEOTIDES, A MARKER OF INVITRO TUMOR-CELL CHEMOSENSITIVITY IN COLORECTAL-CANCER 27
Transfer factor: proprietà biologiche e prospettive cliniche 27
Failure of imaging techniques in revealing breast cancer progression 27
Mitomycin C and etoposide in advanced colorectal carcinoma. A clinical and in vitro experience that focuses the problem of schedule dependence in combination therapy 26
CMF with 5-FU in continuous infusion - a pilot study 26
Variazioni della concentrazione plasmatica di triptofano libero (TRPL) in corso di terapia con cisplatino 26
Development of a lambda chain synthesyzing clone during the course of a non producer myeloma. 24
RUBOXYL - PHASE-I TRIAL AND CLINICAL PERSPECTIVES 23
Ruboxyl, a Daunorubicin analog, in colorectal cancer therapy: preclinicl study. 22
Evaluation of hypothalamic activity in cancer anorexia by functional magnetic resonance 15
Modificazioni della concentrazione plasmatica di triptofano libero (TRP-L) in corso di emesi da cisplatino 14
Neuroimaging of hypothalamic activity in cancer anorexia evacuate by functional magnetic resonance 13
In vitro evaluation of drugs active in colorectal carcinoma therapy: A preliminary study in view of the clinical use of chemosensitivity tests 8
Totale 4.758
Categoria #
all - tutte 13.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.638


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020671 0 0 0 0 0 121 115 130 95 110 76 24
2020/2021432 61 59 14 31 15 56 6 37 27 78 34 14
2021/2022798 9 57 56 31 121 19 13 81 67 77 94 173
2022/2023865 184 118 59 78 109 97 17 73 62 37 26 5
2023/2024332 30 57 18 25 29 47 2 15 1 43 28 37
2024/2025249 32 7 76 13 59 62 0 0 0 0 0 0
Totale 4.758